Previous 10 |
home / stock / otsky / otsky news
Alphabet's ( GOOGL , GOOG ) Project Baseline is a data platform from the Verily unit that wants to develop a "well-defined reference" of good health. More news on: Alphabet Inc., Alphabet Inc., Novartis AG, Tech stocks news, Healthcare stocks news, Read more ...
On January 7, 2019, Axsome Therapeutics ( AXSM ) announced results from an 80-patient trial of bupropion vs AXS-05 (bupropion with dextromethorphan) in major depressive disorder ((MDD)). I recently wrote about results from the trial and the five additional upcoming catalysts for AXSM. Compar...
Otsuka Pharmaceutical Company ( OTCPK:OTSKF )( OTCPK:OTSKY ) and development partner H. Lundbeck A/S ( OTC:HLUKF )( OTCPK:HLUYY ) announce positive results from a Phase 2 clinical trial evaluating the combination of brexpiprazole and Pfizer's ( PFE +0.7% ) Zoloft (sertraline HCl) for t...
The following slide deck was published by Otsuka Holdings Co. Ltd. ADR in conjunction with their 2018 Q2 earnings Read more ...
The following slide deck was published by Otsuka Holdings Co. Ltd. ADR in conjunction with their 2018 Q1 earnings Read more ...
The FDA approves Otsuka Pharmaceutical's ( OTCPK:OTSKF )( OTCPK:OTSKY ) JYNARQUE (tolvaptan) to slow the decline in kidney function in patients with rapidly progressing autosomal dominant polycystic kidney disease (ADPKD), an inherited disorder characterized by the formation of cysts i...
The following slide deck was published by Otsuka Holdings Co. Ltd. ADR in conjunction with their 2017 Q4 earnings Read more ...
I’m often sloth-like when it comes to selling positions in good companies, but it looks to me like the time to part company with H. Lundbeck A/S ( OTCPK:HLUYY ) ( LUN.CO ) may be close at hand. Despite concerted efforts to differentiate its new product portfolio, Lundbeck is strugglin...
News, Short Squeeze, Breakout and More Instantly...
Otsuka Holdings Co. Ltd. ADR Company Name:
OTSKY Stock Symbol:
OTCMKTS Market:
Ginkgo Bioworks (DNA) went public last September through an SPAC deal with Soaring Eagle Acquisition Corporation, a blank-check company led by former MGM CEO Harry Sloan. However, the stock has nosedived in price since its market debut. In addition, given an ongoing investigation into the com...
Biotech company Cassava Sciences (SAVA) is known for its Alzheimer’s drug, currently in phase three clinical trials. The stock has gained triple digits so far this year. However, with the SEC investigating claims that the company allegedly manipulated its prior clinical trial results, ...